Scientist.com, with the slogan "Faster Science®," has established itself as the world's leading AI-powered marketplace for medical research. The company, founded in 2007 and headquartered in the United States, aims to facilitate the discovery of life-saving medicines at a reduced time and cost, with the ambitious mission of curing all human diseases by 2050. By providing a platform for scientists to connect, exchange ideas, and transact online seamlessly, Scientist.com has successfully accelerated and lowered the cost of medical research. The company's impact is evident in its impressive clientele, including 20 of the world’s top 30 pharmaceutical companies, 80 biotechnology firms, and the US National Institutes of Health (NIH), all utilizing Scientist.com's enterprise marketplaces. Notably, Scientist.com recently secured a significant $5.54M Venture Round investment in December 2022, showcasing investor confidence in the company's mission and potential for growth. Scientist.com's innovative approach and widespread adoption signify its pivotal role in revolutionizing the biotechnology industry. With a strong focus on collaboration and efficiency, the company remains at the forefront of driving advancements in medical research.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | $5.54M | - | 09 Dec 2022 | |
Venture Round | $7.37M | 2 | Gordon Asset Management | 23 Dec 2019 |
Series C | $24.00M | 6 | Leerink Transformation Partners, Jack Giarraputo +1 | 15 May 2017 |
Series B | Unknown | 1 | Gordon Asset Management | 25 Mar 2015 |
Series B | $3.00M | 1 | 25 Mar 2014 |
No recent news or press coverage available for Scientist.com.